Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.semerg.2016.02.014 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Case of Bullous Sweet's Syndrome Associated With Esophageal Adenocarcinoma.
Cureus
January 2024
Dermatology, University of South Florida Morsani College of Medicine, Tampa, USA.
Sweet's syndrome (SS), or acute febrile neutrophilic dermatosis, characteristically presents with fever, dermal neutrophilic infiltrates, and neutrophilia. It typically manifests as tender erythematous plaques; however, various variants are documented, including bullous. Malignancy-associated Sweet's syndrome (MASS) can present as a paraneoplastic syndrome in those with established cancers or with undiagnosed malignancies.
View Article and Find Full Text PDFDermoscopic Differentiation of Blister Beetle Dermatitis and Herpes Zoster: an Observational Study.
Dermatol Pract Concept
November 2022
First Department of Dermatology, School of Medicine, Faculty of Health Sciences, Aristotle University, Thessaloniki, Greece.
Introduction: Blister beetle dermatitis (BBD) and herpes zoster (HZ) manifest suddenly with vesicular lesions mimicking each other and progress rapidly. But a lack of definite differentiating criteria yearns the need for better investigating modality. Though histopathology persuades the need, is an invasive procedure, commonly deferred.
View Article and Find Full Text PDFAnti-p200 pemphigoid mimicking erythema multiforme.
JAAD Case Rep
March 2022
Department of Dermatology, Saint-Vincent de Paul Hospital, Lille Catholic University, Lille, France.
Bullous Erythema Multiforme Secondary to Trimethoprim-Sulfamethoxazole Use, Treated With Cyclosporine in a 91-Year-Old Male.
Cureus
September 2021
Internal Medicine, SBH Health System, New York, USA.
Erythema multiforme is an acute, immune-mediated, mucocutaneous condition in which 90% of cases are triggered by infection. The second most common cause is drug-induced. It classically presents with itchy, burning targetoid lesions on the skin and mucous membranes.
View Article and Find Full Text PDFBullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report.
J Infect Public Health
October 2021
Icahn School of Medicine at Mount Sinai/NYC Health + Hospitals Queens, NY, USA. Electronic address:
Background: In December 2020, Moderna released the mRNA-1273 vaccine. The most common side effects are headache, muscle pain, redness, swelling, and tenderness at the injection site. In addition, there have been dermatological adverse events, such as hypersensitivity reactions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!